Law Firm News

---

Law Firm News

Firm Name

News Title

News

News Date

25383 matches |  2234-2240 displayed

1  316 317 318 319 320  3627

---

Thompson Hine LLP

Thompson Hine Advises Goodyear in $1.475 Billion Transaction
The Goodyear Tire & Rubber Company and Veyance Technologies, Inc. have closed The Carlyle Group's acquisition of Goodyear's engineered products division for $1.475 billion, announced March 23, 2007. Thompson Hine LLP advised Goodyear in the transaction. Goodyear's engineered products division serves customers in the industrial, military and automotive industries and employs approximately 6,500 people in 32 countries.

The Thompson Hine team that advised Goodyear was led by April Miller Boise, a partner in the firm's Corporate Transactions & Securities group in the Cleveland office. Boise was assisted by Garrett Evers, a Corporate Transactions & Securities partner in the New York office; Jim Koenig, who advised on international tax matters; Tom Coyne, who provided counsel on real estate issues; and Megan Dortenzo, who advised on intellectual property and information technology matters. The Thompson Hine team also coordinated counsel in 12 foreign countries and was supported by a cross-functional team of lawyers, paralegals and staff from a number of practice areas.

Attorneys from Covington & Burling LLP also advised Goodyear in this transaction.

08-01-2007

---

Stoel Rives, LLP

Stoel Rives Attorney Walt Sinclair to lead Corporate Counsel College for the International Association of Defense Council
Walt Sinclair, a trial attorney at the Boise office of Stoel Rives LLP, has been named the dean of the Corporate Counsel College for the International Association of Defense Counsel, to be held April 24 and 25, 2008 in Chicago, Illinois.

Typically, about 60 top corporate attorneys and 60 top trial attorneys from around the country attend the College. During the instructional sessions, moderators present legal problems of interest to the corporate counsel to panelists and the audience. The panelists and moderators apply their knowledge and experience to make recommendations of potential methods of response and resolutions to the legal challenges of corporate counsel, and then these are discussed with the audience.

As Dean of the College, Sinclair, a business and complex litigation trial attorney, will recruit a corporate advisory committee, design the program around topics of interest to in-house corporate counsel, outline the theme and topics for presentation and discussion, and recruit highly talented corporate counsel and trial attorneys from around the United States to put on the program.

08-01-2007

---

Pillsbury Winthrop Shaw Pittman LLP

White Collar Litigator Daniel Margolis Joins Pillsbury’s New York Office as Partner
Pillsbury Winthrop Shaw Pittman LLP today announced that Daniel Margolis has joined the firm’s New York office as partner in the Corporate Investigations & White Collar Defense group.

“We’ve targeted the White Collar Defense group as one of Pillsbury’s key growth areas in 2007. Dan adds depth to the group, and materially strengthens our ability to attract new, high-caliber work from our current financial clients and on matters related to securities and banking fraud investigations, asset forfeiture and money laundering,” said Ken Taber, co-head of the firm’s National Litigation practice.

Margolis joins Pillsbury from WilmerHale, where he was a junior partner focusing on white-collar criminal defense work, conducting internal corporate investigations and representing individuals and companies before the Securities and Exchange Commission and other government offices and agencies. His practice included matters involving health care fraud, public corruption and various securities offenses including market timing, stock option backdating and accounting improprieties.

Margolis also served for four years as an Assistant U.S. Attorney (AUSA) in the Southern District of New York. As an AUSA, he handled a wide variety of white-collar criminal prosecutions and civil forfeiture actions, including prosecutions involving securities fraud, financial institution fraud, investment fraud, money laundering, corporate crime and health care fraud. He tried numerous white-collar criminal cases to verdict, including the successful prosecution of a massive international conspiracy that defrauded 20 banks worldwide of over $700 million, widely regarded as the largest commercial loan fraud prosecution in history.

In 2004, Margolis received the Attorney General’s John Marshall Award, the Justice Department’s highest award presented to attorneys for excellence in legal performance, for his work on a civil forfeiture action against an operator of a money exchange service in the United Arab Emirates transferring millions of dollars from the U.S. to Iran without U.S. government approval. Margolis has also received awards from the Organized Crime Drug Enforcement Task Force and the Narcotic Enforcement Officers Association for his successful prosecution of 16 defendants for laundering millions of dollars of Colombian drug money through an elaborate network of bank accounts in the U.S. and abroad.

“Dan's extensive experience as an AUSA and in private practice will bring additional expertise to our corporate investigation and enforcement practice,” said Mark Hellerer, co-head of Pillsbury’s Corporate Investigations & White Collar Defense group. “He will enable us to provide even better service to our clients, particularly financial institutions.”

Margolis holds his J.D., cum laude, from New York University School of Law and an undergraduate degree, magna cum laude, from Binghamton University where he was a member of Phi Beta Kappa.

08-01-2007

---

Orrick LLP

Corporate Partner Joins Orrick in Shanghai
Orrick, Herrington & Sutcliffe LLP announced today that Elizabeth Cole, formerly managing partner of Deacons' Shanghai office, has joined the firm as a partner in its Shanghai office. Cole is the fourth partner Orrick has added to its China offices in the last six months.

"The current Chinese business climate provides enormous opportunity for corporate lawyers, especially those who have experience in investment, information technology and financing," said Christopher Stephens, Managing Partner of Orrick's Asian offices. "Elizabeth's extensive China and Asia-Pacific experience is an important strategic fit for our global corporate and intellectual property practices and our ambitions in China."

Cole's practice focuses on corporate, mergers and acquisitions, information technology, bio-technology and projects and financing matters representing numerous multinational corporations on the establishment, acquisition and operation of their businesses in China and throughout the Asia-Pacific region.

Her extensive experience in regional and cross-border mergers and acquisitions includes advising a U.S. listed medical devices company in connection with the PRC and Hong Kong aspects of its US$175 million acquisition of a PRC based business, a leading European water utility on several investments in PRC water and wastewater treatment companies in Southern China as well as advising numerous other U.S., European and Asian companies on acquisitions, sales and buyouts.

“I have admired Orrick's growth in Asia the past few years, and I believe the firm's global platform will provide great opportunity to grow my practice and attract new clients,” said Cole. "I look forward to working with Orrick's strong corporate and intellectual property teams."

Cole received an LLB with Honours and and a B.A. in Asian Studies from the Australian National University in 1992. She is qualified as a solicitor in New South Wales, England and Wales, Hong Kong and Queensland, as a barrister and solicitor in Victoria, and as an attorney in California. Cole began her legal career with Coudert and spent three years working with the China practice.

08-01-2007

---

Nixon Peabody LLP

Nixon Peabody LLP Expands Its Life Sciences Practice; Experienced Patent Attorney, Jill Uhl, Joins the Firm from EMD Serono, Inc.
Prior to joining Nixon Peabody, Ms. Uhl was U.S. patent counsel for EMD Serono, Inc., where she managed U.S. and foreign litigation and the U.S. intellectual property department, as well as drafting and negotiating collaboration, licensing, and strategic alliance agreements. She also has extensive experience in all aspects of biotech and biochemical prosecution and litigation.

Susan Robfogel, leader of Nixon Peabody’s life sciences practice said, “We’re excited to welcome Jill to Nixon Peabody. Jill’s background is a strong asset to the firm as she has extensive knowledge and insight into intellectual property issues specifically facing the life sciences community.”

Andrew Glincher, managing partner of Nixon Peabody’s Boston office, added, “Jill’s arrival strengthens our intellectual property and life sciences presence in Boston and beyond. Her knowledge of patent issues in life sciences arena is especially valuable to our biotech clients.”

Ms. Uhl is a member of the American Intellectual Property Law Association and the Boston Patent Law Association and is active in several industry organizations, including BIO and PhRMA. Ms. Uhl graduated from University of Kentucky and earned her J.D. degree from University of Cincinnati.
About Nixon Peabody’s Technology and Intellectual Property Group

Nixon Peabody ranks among the top patent, trademark, and intellectual property litigation firms in the U.S. Its 90-member team includes more than 50 registered patent attorneys, many of whom hold Ph.D.s or other advanced degrees. The team offers a blend of superior legal skills, engineering knowledge, and business judgment to assist clients in maximizing competitive advantages while minimizing risks. Clients include some of the country’s leading academic institutions and research centers, Nobel Prize winners, entrepreneurs, and Fortune 500 companies.
About Nixon Peabody’s Life Sciences Practice

More than 100 attorneys and scientists comprise Nixon Peabody’s life sciences practice, working in close partnership with domestic and international clients to advance their strategic interests at every stage of the company life cycle. Clients include start-ups, established companies, and many of the nation’s most esteemed research institutions. Services include financing, incorporation, intellectual property protection, licensing, mergers and acquisitions and strategic alliances, FDA regulatory counsel, product marketing, and litigation. Nixon Peabody’s 17 office locations reflect the centers for life sciences research and commercialization in the United States, including in Boston, San Francisco, Los Angeles, Philadelphia, and Washington, DC.

08-01-2007

---

Milbank, Tweed, Hadley & McCloy LLP

Mlbank Advises AstraZeneca on $1.4 Billion Global IT Outsourcing Deal with IBM
International law firm Milbank, Tweed, Hadley & McCloy LLP has advised AstraZeneca on a global IT infrastructure outsourcing deal with IBM worth $1.4 billion. The new outsourcing contract extends AstraZeneca’s existing relationship with IBM, covering more countries and a wider range of services and putting in place an innovative contractual framework.

The new contract governs the provision of IT infrastructure services to AstraZeneca’s global business, and is centred around three delivery hubs in the United Kingdom, Sweden and the United States of America. The services to be provided by IBM include infrastructure and application server hosting, storage, a global service desk, e-mail and collaboration services and client management. In all, the new outsourcing arrangements will cover AstraZeneca’s operations in 60 countries worldwide.

The Milbank team was led by London-based partner Sean Keaton and associate Joel Harrison, who were supported by New York partner Steve Nordahl and associate Douglas Barnes, with employment law advice from senior associate Katherine Soanes and associate Dominic Ward. Mannheimer Swartling partner Magnus Wallander provided Swedish law advice on the transaction.

The Milbank team worked in close partnership with a team from the AstraZeneca in-house legal department, led by Legal Counsel Lucy Allison and with the AstraZeneca commercial team led by Mark Turner and James Simmonds. The Milbank and AstraZeneca teams together delivered a package of ground-breaking terms and conditions to support the evolving needs of AstraZeneca.

Milbank partner Sean Keaton said of the transaction, “The unique needs of AstraZeneca required an agile and truly global service delivery, which in turn called for a novel approach to the key commercial aspects of the transaction. This transaction involved a number of commercial arrangements which to our knowledge have never before been adopted in deals of this kind. That these arrangements could be put in place in a contractual framework that meets the requirements of both parties is a credit to AstraZeneca and also to the ability of IBM to respond to its client’s needs.”He also said of the appointment to advise AstraZeneca, “It has been a great pleasure working with AstraZeneca on this transaction and we are delighted that we were trusted to advise on such a key contract. We have been very impressed by the professional way that this transaction was managed by AstraZeneca’s legal department and in turn we hope that our performance has further strengthened the relationship between our two organisations.”AstraZeneca’s Assistant General Counsel Liam McIlveen said, “The successful collaboration between Milbank and the in-house legal team was key to the success of this transaction. We combined Milbank’s market-leading experience and expertise with the in-house team’s thorough knowledge of the AstraZeneca business to deliver a truly creative and innovative contract. The teams worked seamlessly together. We have been extremely pleased with Milbank’s contribution and are very proud of the combined legal team’s work on this pivotal contract for AstraZeneca.”

08-01-2007

---

Latham & Watkins

Latham & Watkins Adds Experienced M&A Partner in New York
Latham & Watkins LLP1 is pleased to announce M. Adel Aslani-Far has joined the firm's New York office in the Corporate Department, effective August 1, 2007. Aslani-Far's practice focuses on mergers and acquisitions, tender offers, stock and asset acquisitions, recapitalizations, joint ventures and related financings.

Aslani-Far has substantial experience in public and private M&A transactions representing large multinational companies and investment banks. In addition, he has handled several special committee engagements and regularly counsels clients with respect to corporate governance and defensive matters.

"We have built one of the strongest M&A teams in New York, which consistently appears at the top of the league tables, and are proud of our reputation for handling some of the largest, most complex M&A and private equity deals in the market. The M&A group continues to be one of our strongest strategic growth areas, and the team's track record and deep skill base gives us a competitive edge in a competitive market, " said David Gordon, New York Office Managing Partner of Latham & Watkins. "Adel is a highly accomplished mergers and acquisitions attorney who has shown great leadership in the field. He will be a tremendous asset to the firm and its clients."

Charles Nathan, Global Co-Chair of Latham & Watkins' Mergers & Acquisitions Practice Group said: "Adel is highly regarded among the New York mergers and acquisitions bar. His stature reflects his experience, skills and drive. Adel's track record advising on high profile matters strengthens Latham's reputation as a 'go to' firm for complex domestic and cross-border M&A transactions."

"I am pleased to be joining the Latham & Watkins team," said Aslani-Far. "Latham's vibrant mergers and acquisitions practice, combined with the firm's long-term strategic vision, depth of expertise and global presence, present a unique opportunity for me to grow my practice."

Aslani-Far joins Latham & Watkins from Dewey Ballantine LLP, where he has been a partner since 2002. He graduated from Columbia University in 1990 and received his law degree from Georgetown University in 1993.

08-01-2007

---

25383 matches |  2234-2240 displayed

1  316 317 318 319 320  3627